neobookRx
GuidelinesOther guideline

References

References

  1. Marcus DA. Epidemiology of cancer pain. Curr Pain Headache Rep 2011; 15: 231-234.
  2. Paice JA, Ferrell B. The management of cancer pain. CA Cancer J Clin 2011; 61: 157-182.
  3. Harding R, Selman L, Agupio G, et al. The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countries. Eur J Cancer 2011; 47: 51-56.
  4. Open Society Foundations. Public Health Fact Sheet: Palliative Care as a Human Right. May 1st 2011. http://www.opensocietyfoundations.org/publications/palliative-care-human-right-fact-sheet. Accessed 4 April 2013.
  5. Lohman D, Schleifer R, Amon JJ. Access to pain treatment as a human right. BMC Medicine 2010, 8:8. http://www.biomedcentral.com/1741-7015/8/8.
  6. Beck SL. An ethnographic study of factors influencing cancer pain management in South Africa. Cancer Nursing 2000; 23(2): 91-99.
  7. Beck SL. Health policy, health services, and cancer pain management in the new South Africa. J Pain Symptom Manage 1999; 17: 16-26.
  8. Gwyther L, Brennan F, Harding R. Advancing palliative care as a human right. J Pain Sympt Manage 2009; 38(5): 767-774.
  9. Scottish Intercollegiate Guidelines Network (SIGN). Control of pain in adults with cancer. National clinical guideline 106. Edinburgh, UK: SIGN; November 2008. Available at http://www.sign.ac.uk. Quick reference guide available at http://www.sign.ac.uk.
  10. Ripamonti CI, Santini D, Maranzano E, et al. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2012; 23(suppl 7): vii39-vii54.
  11. Caraceni A, Hanks G, Kaasa S, et al. Use of opioids in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 2012; 13: e58-e68.
  12. National Institute for Health and Clinical Excellence. Opioids in palliative care: Safe and effective prescribing of strong opioids for pain in palliative care of adults. NICE clinical guideline 140. May 2012. Available at: http://www.guidance.nice.uk/cg140.
  13. World Health Organisation. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. World Health Organisation; Geneva, Switzerland; 2012. Available at: http://apps.who.int/medicinedocs/en/m/abstract/Js19116en/.
  14. Merskey H, Bogduk N; editors. IASP Task Force on Taxonomy: Classification of Chronic Pain. 2nd ed. Seattle USA; 1994. pp209-214. Update 22 May 2012. Available at: http://www.iasp-pain.org/Content/NavigationMenu/GeneralResourceLinks/PainDefinitions/default.htm#Pain. Accessed 26 March 2013.
  15. Teno JM, Okun SN, Casey V, et al. Toolkit of Instruments to Measure End of Life Care (TIME). Resource Guide: Achieving Quality of Care at Life’s End. Center for Gerontology and Health Care Research, Brown University; 2001. http://as800.chcr.brown.edu/pcoc/resourceguide/resourceguide.pdf. Accessed 10 February 2014.
  16. Downing J, Atieno M, Debere S, et al; editors. Beating pain. 2nd ed. Kampala, Uganda: African Palliative Care Association (APCA); 2012.
  17. Raphael J, Ahmedzai S, Hester J, et al. Cancer Pain: Part 1: Pathophysiology; oncological, pharmacological, and psychological treatments: A perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Medicine 2010; 11: 742-764.
  18. Lossignol DA, Dumitrescu C. Breakthrough pain: progress in management. Curr Opin Oncol 2010; 22: 302-306.
  19. Chetty S, Baalbergen E, Bhigjee AI, et al. Clinical practice guidelines for the management of neuropathic pain: expert panel recommendations for South Africa. S Afr Med J 2012; 102(5): 312-325.
  20. Shaikh A, Bentley A, Kamerman PR. Symptomatology of peripheral neuropathy in an African language. PLoS ONE 2013; 8(5): e63986. doi: 10.1371/journal.pone.0063986.
  21. Cushing A, Metcalfe R. Optimizing medicines management: from compliance to concordance. Therapeutics and Clinical Risk Management 2007:3(6): 1047-1058.
  22. World Health Organisation (WHO). Cancer pain relief: with a guide to opioid availability. 2nd ed. Geneva, Switzerland: WHO; 1996.
  23. Cancer Care Ontario/Action Cancer Ontario. Cancer Care Ontario’s Symptom Management Guides-to-Practice: Pain. August 2010. Available at:  https://www.cancercare.on.ca/toolbox/symptools/.
  24. Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 2005; 114(1): 29-36.
  25. HOSPICE Palliative Care Association of South Africa. Management of common symptoms and problems in paediatric palliative care. Available at: http://www.hpca.co.za/resources.
  26. Smith BH, Torrance N, Ferguson JA, et al. Towards a definition of refractory neuropathic pain for epidemiological research. An international Delphi survey of experts. BMC Neurol 2012; 28: 12-29.
  27. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Adult Cancer Pain V.2.2013. Available at NCCN.org.
  28. Berry PH, Covington PC, Dahl JL, et al; editors. Pain: Current understanding of assessment, management and treatments. American Pain Society. Available at http://www.americanpainsociety.org/uploads/pdfs/npc/section_2.pdf. Accessed 5th May 2013.
  29. Powell RA, Downing J, Harding R, et al, on behalf of the APCA M&E Group. Development of the APCA African Palliative Outcome Scale. Journal of Pain and Symptom Management 2007; 33: 229-232.
  30. Puchalski CM, Romer AL. Taking a spiritual history allows clinicians to understand patients more fully. J Pall Med 2000; 3: 129-137.
  31. American Cancer Society. Daily Pain Diary; 2012. Available at: http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-033203.pdf. Accessed 27 March 2013.
  32. Geriatric Pain. http://www.geriatricpain.org/Content/Assessment/Impaired/Pages/default.aspx. Accessed 27 March 2013.
  33. Zwakhalen SM, Hamers JP, Abu-Saad HH, Berger MP. Pain in elderly people with severe dementia: a systematic review of behavioural pain assessment tools. BMC Geriatr 2006; 6: 3.
  34. McNicol ED, Strassels S, Goudas L, et al. NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database of Systematic Reviews 2005, Issue 2. Art. No.: CD005180. doi: 10.1002/14651858.CD005180.
  35. Rainsford KD. Ibuprofen: Pharmacology, efficacy and safety. Inflammopharmacol 2009; 17: 275-342.
  36. Mercadante S, Giarratano A. The long and winding road of non steroidal antiinflammatory drugs and paracetamol in cancer pain management: a critical review. Crit Rev Oncol Hematol 2013; pii: S1040-8428(13)00003-6. doi: 10.1016/j.critrevonc.2013.01.001. [Epub ahead of print].
  37. Stockler M, Vardy J, Pillai A, Warr D. Acetaminophen (paracetamol) improves pain and well-being in people with advanced cancer already receiving a strong opioid regimen: a randomized, double-blind, placebo-controlled cross-over trial. J Clin Oncol 2004; 22(16): 3389-3394.
  38. Hardy J, Raymond E, Charles M. Acetaminophen in cancer pain. J Clin Oncol 2005; 23(7):1586.
  39. Israel FJ, Parker G, Charles M. Lack of benefit from paracetamol (acetaminophen) for palliative cancer patients requiring high-dose strong opioids: a randomized, double-blind, placebo-controlled, crossover trial. J Symptom Manage 2010; 39(3): 548-554.
  40. Twycross R, Wilcock A. Palliative Care Formulary (PCF4). 4th ed. Nottingham, UK: Palliativedrugs.com; 2011.
  41. Vadalouca A, Raptis E, Moka E, et al. Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature. Pain Practice 2011; 12(3): 219-251.
  42. Garcia de Paredes ML, del Moral Gonzalez F, Martinez del Prado P, et al. First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study. Ann Oncol 2011; 22: 924-930.
  43. Wernicke JF, Pritchett YL, D’Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology 2006; 67: 1411-1420.
  44. Mattia C, Coluzzi F. What anaesthesiologists should know about paracetamol (acetaminophen). Minerva Anesthesiol 2009; 644-653.
  45. Gordin V, Weaver MA, Hahn MB. Acute and chronic pain management in palliative care. Best Pract Res Clin Obstet Gynaecol 2001; 15(2): 203-234.
  46. Pantano F, Zoccoli A, Luliani M, et al. New targets, new drugs for metastatic bone pain: a new philosophy. Expert Opin Emerging Drugs 2011; 16(3): 403-405.
  47. Wong R, Wiffen PJ. Bisphosphonates for the relief of pain secondary to bone metastases. Cochrane Database Syst Rev 2002; 2: CD002068.
  48. Pavlakis N, Schmidt R, Stockler M. Bisphosphonates for breast cancer. Cochrane Database Syst Rev 2005; 3: CD003474.
  49. Wong MH, Stockler MR, Pavlakis N. Bisphosphonates and other bone agents for breast cancer. Cochrane Database Syst Rev 2012; 2: CD003474. doi: 10.1002/14651858.CD003474.pub3.
  50. Mhaskar R, Redzepovic J, Wheatley K, et al. Bisphosphonates in multiple myeloma: a network meta-analysis. Cochrane Database Syst Rev 2012; 5: CD003188. doi: 10.1002/14651858.CD003188.pub3.
  51. Yuen KK, Shelley M, Sze WM, et al. Bisphosphonates for advanced prostate cancer. Cochrane Database Syst Rev 2006; 4: CD006250.
  52. Choudhury KB, Mallik C, Sharma S, et al. A randomized controlled trial to compare the efficacy of bisphosphonates in the management of painful bone metastasis. Indian J Palliat Care 2011; 17(3): 210-218.
  53. Lopez-Olivo MA, Shah NA, Pratt G, et al. Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis. Support Care Cancer 2012; 20(11): 2985-2998.
  54. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006; 102(4): 433-441.
  55. Yomiya K, Matsuo N, Tomivasu S, et al. Baclofen as an adjuvant analgesic for cancer pain. Am J Hosp Palliat Care 2009; 26(2): 112-118.
  56. Lussier D, Huskey A, Portenoy RK. Adjuvant analgesics in cancer pain management. The Oncologist 2004; 9: 571-591.
  57. Tytgat GN. Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Curr Med Res Opin 2008; 24(11): 3159-3173.
  58. Ripamonti CI, Easson AM, Gerdes H. Management of malignant bowel obstruction. Eur J Cancer 2008; 44(8): 1105-1115.
  59. Smith FJ. The use of ketamine in cancer palliation. SAJAA 2007; 13(2): 37-41.
  60. Leppert W. Pain management in patients with cancer: Focus on opioid analgesics. Curr Pain Headache Rep 2011; 15: 271-279.
  61. British Pain Society. Opioids for persistent pain: Good Practice. A consensus statement prepared on behalf of the British Pain Society, the Faculty of Pain Medicine of the Royal College of Anaesthetists, the Royal College of General Practitioners and the Faculty of Addictions of the Royal College of Psychiatrists. London, UK: British Pain Society; 2010.
  62. Smith H, Bruckenthal P. Implications of opioid analgesia for medically complicated patients. Drugs Aging 2010; 417-433.
  63. Kamerman PR, Mitchell D. Current perspectives on HIV-related pain and its management: insights from Sub-Saharan Africa. Pain Management 2011; 1:587-596.
  64. Porphyria South Africa; Universities of Cape Town and KwaZulu Natal. http://www.porphyria.uct.ac.za/professional/prof-home.htm.
  65. European Medicines Agency. Assessment report for meprobamate-containing medicinal products for oral use. Procedure number: EMEA/H/A-107/1316. 30 March 2012. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/meprobamate_107/WC500128266.pdf. Accessed 3 April 2013.
  66. Derry CJ, Derry S, Moore RA. Caffeine as an analgesic adjuvant for acute pain in adults. Cochrane Database of Systematic Reviews 2012, Issue 3. Art. No.: CD009281. doi: 10.1002/14651858.CD009281.pub2.
  67. Raphael J, Hester J, Ahmedzai S, et al. Cancer Pain: Part 2: Physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Medicine 2010; 11: 872-896.
  68. Meyerhardt JA, Giovannuci EL, Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006; 24(22): 3527-3534.
  69. Meyerhardt, Heseltine S, Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 2006;24:3535-3541.
  70. Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 1997; 24(6): 991-1000.
  71. Courneya KS, Friedenreich CM, Physical exercise and quality of life following cancer diagnosis: a literature review. Ann Behav Med 1999; 21(2): 171-179.
  72. McNeely ML, Parliament M, Courneya KS, et al. A pilot study of a randomised controlled trial to evaluate the effects of progressive resistance exercise training on shoulder dysfunction caused by spinal accessory neuropraxia/ neurectomy in head and neck cancer survivors. Head Neck 2004; 26(6): 518-530.
  73. Courneya KS, Mackey JR, Bell GJ, et al. Randomised controlled trial of exercise training in postmenopausal breast cancer survivors: cardiopulmonary and quality of life outcomes. J Clin Oncol 2003; 21: 1660-1668.
  74. Moseley GL, Nicholas MK, Hodges PW. A randomised controlled trial of intensive neurophysiology education in chronic low back pain. Clin J Pain 2004; 20: 324-330.
  75. Moseley GL. Widespread brain activity during an abdominal task markedly reduced after pain physiology education: fMRI of a single patient with chronic low back pain. Aus J Physiother 2005; 51(1): 49-52.
  76. Gaeta S, Price KJ. End-of-life issues in critically ill cancer patients. Crit Care Clin 2010; 26: 219-227.
  77. Mularski RA, Puntillo K, Varkey B, et al. Pain management within the palliative and end-of-life care experience in the ICU. Chest 2009; 135: 1360-1369.
  78. Payen J-F, Bru O, Bosson J-L, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med 2001; 29: 2258-2263.
  79. Hicks CL, von Baeyer CL, Spafford P, et al. Faces Pain Scale-Revised: Toward a common metric in pediatric pain measurement. Pain 2001; 93: 173-183. Instructions and translations. Available at: http://www.usask.ca/childpain/fpsr/
  80. Hall SM. Consumer information about the non-therapeutic use of aspirin in South African children: a public health challenge. S Afr Pharm J 2012; 79(10): 35-42.
  81. Jassal SS, editor. APPM Master Formulary 2012. 2nd ed. UK: Association of Paediatric Palliative Medicine; 2012.

Drugs mentioned

NeoHealth® ID 17143 · updated 9/15/2021